Domestic drug market shows resilience, posts strong growth in October

Maintains the growth momentum from September with a 9.6 per cent growth

The pandemic blues seem to be over for the domestic drug industry, which has shown strong resilience in the last three months by maintaining a growth momentum.
 

In October, the Indian pharma market clocked a strong 9.6 per cent growth after growing by 4.5 per cent in September and 2.2 per cent in August.
 

Data from market research firm AIOCD AWACS shows that chronic therapies have continued to do well during October while some of the other therapy areas like respiratory (still in negative growth territory) have seen some revival.
 

Rakesh Dave, president of AIOCD AWACS, however, pointed out that